multidrug-resistant plasmodium vivax associated with severe and fatal malaria a prospective study in papua, indonesia耐多药相关间日疟原虫严重和致命疟疾巴布亚的前瞻性研究,印度尼西亚.pdfVIP

下载本文档

0
0
约7.46万字
约 10页
2017-09-01 发布于上海
举报
版权申诉

multidrug-resistant plasmodium vivax associated with severe and fatal malaria a prospective study in papua, indonesia耐多药相关间日疟原虫严重和致命疟疾巴布亚的前瞻性研究,印度尼西亚.pdf

1、有哪些信誉好的足球投注网站（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

multidrug-resistant plasmodium vivax associated with severe and fatal malaria a prospective study in papua, indonesia耐多药相关间日疟原虫严重和致命疟疾巴布亚的前瞻性研究,印度尼西亚

PLoS MEDICINE Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia 1 2 3 4,5 4,6 1 Emiliana Tjitra , Nicholas M. Anstey , Paulus Sugiarto , Noah Warikar , Enny Kenangalem , Muhammad Karyana , Daniel A. Lampah4,6, Ric N. Price2,7* 1 National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia, 2 International Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia, 3 Mitra Masyarakat Hospital, Timika, Papua, Indonesia, 4 Menzies School of Health Research-National Institute of Health Research and Development Malaria Research Program, Timika, Indonesia, 5 International SOS, Tembagapura, Papua, Indonesia, 6 District Health Authority, Timika, Papua, Indonesia, 7 Centre for Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom Funding: The study was funded by A B S T R A C T the Wellcome Trust and National Health and Medical Research Council (NHRMC) (Wellcome Trust International Collaborative Research Background Grant GR071614MA-NHMRC ICRG ID 283321). NMA is supported by an Multidrug-resistant Plasmodium vivax (Pv) is widespread in eastern Indonesia, and emerging NHMRC Practitioner Fellowship. RNP elsewhere in Asia-Pacific and South America, but is generally regarded as a benign disease. The is funded by a Wellcome Trust aim of the study was to review the spectrum of disease associated with malaria due to Pv and P.